Literature DB >> 28646030

Metabolic remodeling in hypertrophied and failing myocardium: a review.

Mark A Peterzan1, Craig A Lygate2, Stefan Neubauer2, Oliver J Rider2.   

Abstract

The energy starvation hypothesis proposes that maladaptive metabolic remodeling antedates, initiates, and maintains adverse contractile dysfunction in heart failure (HF). Better understanding of the cardiac metabolic phenotype and metabolic signaling could help identify the role metabolic remodeling plays within HF and the conditions known to transition toward HF, including "pathological" hypertrophy. In this review, we discuss metabolic phenotype and metabolic signaling in the contexts of pathological hypertrophy and HF. We discuss the significance of alterations in energy supply (substrate utilization, oxidative capacity, and phosphotransfer) and energy sensing using observations from human and animal disease models and models of manipulated energy supply/sensing. We aim to provide ways of thinking about metabolic remodeling that center around metabolic flexibility, capacity (reserve), and efficiency rather than around particular substrate preferences or transcriptomic profiles. We show that maladaptive metabolic remodeling takes multiple forms across multiple energy-handling domains. We suggest that lack of metabolic flexibility and reserve (substrate, oxidative, and phosphotransfer) represents a final common denominator ultimately compromising efficiency and contractile reserve in stressful contexts.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  creatine kinase; heart failure; hypertrophy; substrate metabolism

Mesh:

Year:  2017        PMID: 28646030     DOI: 10.1152/ajpheart.00731.2016

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  32 in total

Review 1.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

Review 2.  Genetic and epigenetic regulation of cardiomyocytes in development, regeneration and disease.

Authors:  Miao Cui; Zhaoning Wang; Rhonda Bassel-Duby; Eric N Olson
Journal:  Development       Date:  2018-12-20       Impact factor: 6.868

3.  Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Authors:  Oliver Dörr; Claudia Walther; Christoph Liebetrau; Till Keller; Hannes Tabert; Niklas Boeder; Matthias Bayer; Pascal Bauer; Helge Möllmann; Luise Gaede; Christian Troidl; Sandra Voss; Timm Bauer; Christian W Hamm; Holger Nef
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882

4.  Metabolic remodeling of substrate utilization during heart failure progression.

Authors:  Liang Chen; Jiangping Song; Shengshou Hu
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

Review 5.  Cardiac metabolic remodelling in chronic kidney disease.

Authors:  Nikayla Patel; Muhammad Magdi Yaqoob; Dunja Aksentijevic
Journal:  Nat Rev Nephrol       Date:  2022-05-30       Impact factor: 42.439

6.  Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Authors:  Oliver Dörr; Claudia Walther; Christoph Liebetrau; Till Keller; Thomas Sommer; Niklas Boeder; Matthias Bayer; Pascal Bauer; Helge Möllmann; Luise Gaede; Christian Troidl; Sandra Voss; Timm Bauer; Christian W Hamm; Holger Nef
Journal:  Clin Cardiol       Date:  2018-08-20       Impact factor: 2.882

7.  Increased myocardial oxygen consumption rates are associated with maladaptive right ventricular remodeling and decreased event-free survival in heart failure patients.

Authors:  Ali Ahmadi; Jennifer M Renaud; Steven Promislow; Ian G Burwash; Girish Dwivedi; Ran Klein; Jason G E Zelt; Robert A deKemp; Rob S Beanlands; Lisa M Mielniczuk
Journal:  J Nucl Cardiol       Date:  2020-05-07       Impact factor: 5.952

8.  Response by Peterzan et al to Letter Regarding Article, "Cardiac Energetics in Patients With Aortic Stenosis and Preserved Versus Reduced Ejection Fraction".

Authors:  Mark A Peterzan; Stefan Neubauer; Christopher T Rodgers; Oliver J Rider
Journal:  Circulation       Date:  2020-11-30       Impact factor: 29.690

Review 9.  Non-invasive investigation of myocardial energetics in cardiac disease using 31P magnetic resonance spectroscopy.

Authors:  Mark A Peterzan; Andrew J M Lewis; Stefan Neubauer; Oliver J Rider
Journal:  Cardiovasc Diagn Ther       Date:  2020-06

Review 10.  Use of cardiac magnetic resonance to detect changes in metabolism in heart failure.

Authors:  William D Watson; Jack J J Miller; Andrew Lewis; Stefan Neubauer; Damian Tyler; Oliver J Rider; Ladislav Valkovič
Journal:  Cardiovasc Diagn Ther       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.